Publiziert in: Marktpuls, Unternehmen, Neuemissionen
Frei

CREDIT SUISSE NEW ISSUE: 6 American Call Warrants on Novartis Freitag, 03. Juni 2022 - 14:39

Dear Investor

Please find hereafter the details for these new issues:

Ticker

Valor

ISIN

Underlying

Spot

Strike

Ratio

Maturity

Type

Issue price

Impl. Vola

PDF File

QNOVCS 

11 620 3151 

CH 116 203 151 7 

Novartis AG 

CHF 86.00 

CHF 92.00 

15:1 

17.03.2023 

Call 

CHF 0.24 

20.04% 

QNOVCS_116203151_CW_TSi.pdf

RNOVCS 

11 620 3152 

CH 116 203 152 5 

Novartis AG 

CHF 86.00 

CHF 96.00 

15:1 

17.03.2023 

Call 

CHF 0.16 

19.68% 

RNOVCS_116203152_CW_TSi.pdf

SNOVCS 

11 620 3153 

CH 116 203 153 3 

Novartis AG 

CHF 86.00 

CHF 100.00 

15:1 

17.03.2023 

Call 

CHF 0.11 

19.53% 

SNOVCS_116203153_CW_TSi.pdf

TNOVCS 

11 620 3154 

CH 116 203 154 1 

Novartis AG 

CHF 86.00 

CHF 92.00 

15:1 

15.12.2023 

Call 

CHF 0.37 

20.24% 

TNOVCS_116203154_CW_TSi.pdf

UNOVCS 

11 620 3155 

CH 116 203 155 8 

Novartis AG 

CHF 86.00 

CHF 100.00 

15:1 

15.12.2023 

Call 

CHF 0.22 

19.82% 

UNOVCS_116203155_CW_TSi.pdf

VNOVCS 

11 620 3156 

CH 116 203 156 6 

Novartis AG 

CHF 86.00 

CHF 110.00 

15:1 

15.12.2023 

Call 

CHF 0.12 

19.84% 

VNOVCS_116203156_CW_TSi.pdf


Please visit our website http://www.credit-suisse.com/derivatives to see the complete list of our products.

The warrants will be placed directly in the secondary market. Please call 044/335 76 00.

Kind regards

CREDIT SUISSE AG
Investment Banking
Equity Derivatives & Structured Products
Uetlibergstrasse 231
8070 Zürich, Switzerland
Tel: +41 44 - 335 76 00
Fax: +41 44 - 333 78 08

www.credit-suisse.com

This message may contain confidential, proprietary or legally privileged information and is intended only for the use of the addressee named above. No confidentiality or privilege is waived or lost by any mistransmission. If you are not the intended recipient of this message you are hereby notified that you must not use, disseminate, copy it in any form or take any action in reliance on it. If you have received this message in error please delete it and any copies of it and notify the sender immediately. Credit Suisse Group and its subsidiaries reserve the right to intercept and monitor any e-mail communication through its networks if legally allowed.